Tissue Doppler imaging in the evaluation of patients with cardiac amyloidosis

Current Opinion in Cardiology

Volumn 19, Issue 5, 2004, Pages 464-471

  Sallach, John A ^a   Klein, Allan L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cardiac amyloidosis; Echocardiography; Strain; Strain rate; Tissue Doppler imaging

Indexed keywords

AMYLOID;

DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; DOPPLER FLOWMETRY; EVALUATION; HEART AMYLOIDOSIS; HUMAN; IMAGING SYSTEM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SURVIVAL RATE;

AMYLOIDOSIS; BLOOD FLOW VELOCITY; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY, DOPPLER; HUMANS; STRESS, MECHANICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 4544235462     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000136451.63329.17     Document Type: Review

References (40)

1. Dubrey S, Falk R: Amyloidosis and the heart. Br J Cardiol 1995, 7:193-199.
2. Klein AL, Hatle L, Taliercio C, et al.: Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. Circulation 1991, 83:808-816.
3. Gertz MA, Kyle RA: Primary systemic amyloidosis - a diagnostic primer. Mayo Clin Proc 1989, 64:1505-1519.
4. Cohen AS, Jones LA: Advances in amyloidosis. Curr Opin Rheumatol 1993, 5:62-76.
5. Dubrey S, Cha K, Anderson J, et al.: The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. Q J Med 1998, 91:141-157.
6. Nihoyannopoulos P: Amyloid heart disease. Curr Opin Cardiol 1987, 2:371-376.
7. Browning MJ, Banks RA, Tribe CR, et al.: Ten years experience of an amyloid clinic - a clinicopathological survey. Q J Med 1985, 54:213-227.
8. Kyle RA, Greipp PR: Amyloidosis: clinical and laboratory features in 229 cases. Mayo Clin Proc 1983, 58:665-683.
9. Smith TJ, Kyle RA, Lie JT: Clinical significance of histopathologic pattern of cardiac amyloidosis. Mayo Clin Proc 1984, 59:547-555.
10. Moyssakis I, Triposkiadis F, Rallidis L, et al.: Echocardiographic features of primary, secondary and familial amyloidosis. Eur J Clin Invest 1999, 29:484-489.
11. Cueto-Garcia L, Reeder GS, Kyle RA, et al.: Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol 1985, 6:737-743.
12. Chew C, Wiady GM, Raphael MJ, et al.: The functional defect in amyloid heart disease. The "stiff heart" syndrome. Am J Cardiol 1975, 36:438-444.
13. Swanton RH, Brooksbey IAB, Davies MJ, et al.: Systolic and diastolic ventricular function in cardiac amyloidosis. Am J Cardiol 1977, 39:658-664.
14. Roberts WC, Waller BF: Cardiac amyloidosis causing cardiac dysfunction: analysis of 54 necropsy patients. 1983, 52:137-146.
15. Hongo M, Ikeda S: Echocardiographic assessment of the evolution of amyloid heart disease: a study with familial amyloid polyneuropathy. Circulation 1983, 73:249-256.
16. Kyle RA: Amyloidosis. Clin Haematol 1982, 11:151-180.
17. Tyberg TI, Goodyer AVN, Hurst VWM: Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis. Am J Cardiol 1981, 47:791-796.
18. Falk RH, Plehn J, Deering T, et al.: Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol 1987, 59:418-422.
19. Klein AL, Oh JK, Miller FA, et al.: Two-dimensional and Doppler echocardiographic assessment of infiltrative cardiomyopathy. J Am Soc Echocardiogr 1988, 1:48-59.
20. Hamer JPM, Janssen S, Van Rijswijk MH, et al.: Amyloid cardiomyopathy in systemic non-hereditary amyloidosis. Eur Heart J 1992, 13:623-627.
21. Gertz MA, Lacy MQ, Dispenzieri A: Amyloidosis. Hematol/Oncol Clin North Am 1999, 13:1211-1233.
22. Siqueira-Filho AG, Cunha CLP, Tajik AJ, et al.: M-mode and two-dimensional echocardiographic features in cardiac amyloidosis. Circulation 1981, 63:188-196.
23. Comenzo RL, Vosburgh E, Falk RH, et al.: Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood 1998, 91:3662-3670.
24. Klein AL, Hatle LK, Burstow DJ, et al.: Doppler characterization of left ventricular diastolic function in cardiac amyloidosis:. J Am Coll Cardiol 1989, 13:1017-1026.
25. Klein AL, Hatle LK, Taliercio CP, et al.: Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990, 16:1135-1141.
26. Elliott PM, Mahon NG, Matsumura Y, et al.: Tissue Doppler features of cardiac amyloidosis. Clin Cardiol 2000, 23:701.
27. Abdalla I, Murray D, Lee JC, et al.: Duration of pulmonary venous atrial reversal flow velocity and mitral inflow A wave: new measure of severity of cardiac amyloidosis. J Am Soc Echocardiogr 1998, 11:1125-1133.
28. McCarthy R, Kasper E: A review of the amyloidoses that infiltrate the heart. Clin Cardiol 1998, 21:556-561.
29. Tei C, Lieng HL, Hodge DO, et al.: New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995, 26:357-366.
30. Tei C, Dujardin KS, Hodge DO, et al.: Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996, 28:658-664.
31. St John Sutton MG, Reichek N, Kastor JA, et al.: Computerized M-mode echocardiographic analysis of left ventricular dysfunction in cardiac amyloid. Circulation 1982, 66:790-799.
32. Garcia MJ, Rodriguez L, Ares M, et al.: Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol 1996, 27:108-114.
33. Oki T, Tabata T, Yamada H, et al.: Right and left ventricular wall motion velocities as diagnostic indicators of constrictive pericarditis. Am J Cardiol 1998, 81:465-470.
34. Oki T, Mishiro Y, Yamada H, et al.: Detection of left ventricular regional relaxation abnormalities and asynchrony in patients with hypertrophic cardiomyopathy with the use of tissue Doppler imaging. Am Heart J 2000, 139:497-502.
35. Oki T, Tabata T, Yamada H, et al.: Clinical application of pulsed Doppler tissue imaging for assessing abnormal left ventricular relaxation. Am J Cardiol 1997, 79:921-928.
36. Vinereanu D, Ionescu AA, Fraser AG: Assessment of left ventricular long axis contraction can detect early myocardial dysfunction in asymptomatic patients with severe aortic regurgitation. Heart 2001, 85:30-36.
37. Koyama J, Ray-Sequin PA, Davidoff R, et al.: Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol 2002, 89:1067-1071. This study demonstrates that in CA patients, pulsed TDI demonstrates early diastolic dysfunction before clinical congestive heart failure and that systolic wall motion abnormalities are seen only once heart failure is present.
38. Palka P, Lange A, Donnelly E, et al.: Doppler tissue echocardiographic features of cardiac amyloidosis. J Am Soc Echocardiogr 2002, 15:1353-1360. This is the first study to examine the role of color M-mode TDI-derived MMV and MVG in the diagnosis of CA patients.
39. Oki T, Tanaka H, Yamada H, et al.: Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol 2004, 93:864-869. This study used pulsed and color-coded TDI to quantitatively evaluate regional LV myocardial function in CA. The authors demonstrated that MVP demonstrates a characteristic serrated pattern in CA patients.
40. Koyama J, Ray-Sequin P, Falk RH: Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation 2003, 107:2446-2452. Elegant study of CA patients documenting that strain and SR demonstrate early impairment in systolic function before clinical CHF, not seen with myocardial TDI velocities.